Form 4: LM Funding director Frank Silcox awarded 104,760 options

Rhea-AI Filing Summary

Frank Charles Silcox, a director of LM Funding America, Inc. (LMFA), was granted stock options totaling 104,760 shares on 08/27/2025. The options have an exercise price of $1.26 and expire on 08/27/2035. The award was made under the company’s Non-Employee Director Compensation Plan as amended November 18, 2022. The options vest one-half 180 days after the grant and the remaining one-half on the first anniversary of the grant date. Following the reported transaction the filing shows direct beneficial ownership of 104,760 underlying common shares through these options.

Positive

• Grant of 104,760 stock options to align director incentives with shareholders
• Exercise price disclosed at $1.26, and a clear expiration date of 08/27/2035
• Defined vesting schedule (one-half at 180 days, one-half at first anniversary) provides clarity on retention terms
• Award made under the company’s Non-Employee Director Compensation Plan, indicating a formal compensation framework

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Director received standard long-term equity compensation; modest governance signal, not a material change to control.

The Form 4 documents a non-employee director option grant of 104,760 options at a $1.26 exercise price, exercisable through 2035, with time-based vesting in two equal tranches. This appears to be routine director compensation under the stated plan and aligns director incentives with long-term shareholder value. The report shows direct beneficial ownership via the option award. The filing contains no indications of accelerated vesting, related-party sales, or other atypical terms.

Executive Compensation Analyst

TL;DR: Award structure is time‑based and typical for non-employee directors; impact on float and expense is modest without further context.

The award’s structure—half vesting at 180 days and half at one year—is a standard retention and alignment mechanism. The exercise price and ten-year term are explicitly stated. The Form 4 does not disclose prior holdings, aggregate dilution impact, or grant valuation, so assessment of materiality to shareholders is limited to the disclosed grant size and terms.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Silcox Frank Charles

(Last) (First) (Middle)

1200 PLATT STREET

SUITE 100

(Street)

TAMPA FL 33606

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LM FUNDING AMERICA, INC. [ LMFA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$1.26	08/27/2025		A		104,760		(1)	08/27/2035	Common Stock	104,760	$0	104,760	D

Explanation of Responses:

1. Option awards to purchase shares of common stock were granted under the Non-Employee Director Compensation Plan, as amended on November 18, 2022. Shares subject to the options will vest as to one-half on the 180th day after the grant date and as to one-half on the date that is the first anniversary of the grant date.

	/s/ Frank Charles Silcox	08/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did LMFA director Frank Charles Silcox receive on 08/27/2025?

The filing shows a grant of 104,760 stock options with an exercise price of $1.26 and expiration 08/27/2035.

How do the options granted to Frank Silcox vest?

The options vest one-half on the 180th day after grant and one-half on the first anniversary of the grant date.

Under which plan were the options granted?

The options were granted under the Non-Employee Director Compensation Plan, as amended on November 18, 2022.

Does the Form 4 show Silcox’s beneficial ownership after the grant?

Yes; the filing reports direct beneficial ownership of 104,760 shares underlying the options following the transaction.

What is the exercise price and term of the options?

The exercise price is $1.26 per share and the options expire on 08/27/2035.